

					
						November 28, 2017 - By Marguerite Chambers
Waddell & Reed Financial, Inc., incorporated on December 24, 1981, is a holding company. The company has market cap of $1.61 billion. The Firm is a mutual fund and asset management company. It has a 13.79 P/E ratio. The Firm provides investment management, investment advisory, investment product underwriting, and distribution and shareholder services administration to Waddell & Reed Advisors group of mutual funds , Ivy Funds, Ivy Funds Variable Insurance Portfolios (Ivy Funds VIP), InvestEd Portfolios and 529 college savings plan (collectively, the Funds), and the Ivy Global Investors Fund SICAV (the SICAV) and its Ivy Global Investors sub-funds (the IGI Funds), and institutional and separately managed accounts.Tiedemann Wealth Management Llc increased Medtronic Plc (MDT) stake by 10.57% reported in 2017Q2 SEC filing. Tiedemann Wealth Management Llc acquired 3,460 shares as Medtronic Plc (MDT)’s stock rose 5.51%. The Tiedemann Wealth Management Llc holds 36,199 shares with $3.21 million value, up from 32,739 last quarter. Medtronic Plc now has $110.20 billion valuation. The stock rose 1.20% or $0.98 reaching $82.39 per share. About 3.14 million shares traded. Medtronic plc. Ordinary Shares (NYSE:MDT) has risen 4.04% since November 28, 2016 and is uptrending. It has underperformed by 12.66% the S&P500.Sterneck Capital Management Llc holds 2.58% of its portfolio in Waddell & Reed Financial, Inc. for 228,783 shares. Continental Advisors Llc owns 386,702 shares or 1.65% of their US portfolio. Moreover, Van Berkom & Associates Inc. has 1.62% invested in the company for 2.37 million shares. The Nebraska-based Cwm Llc has invested 1.29% in the stock. Fuller & Thaler Asset Management Inc., a California-based fund reported 3.41 million shares. About 370,390 shares traded. Waddell & Reed Financial, Inc. (WDR) has declined 11.92% since November 28, 2016 and is downtrending. It has underperformed by 28.62% the S&P500.Analysts await Waddell & Reed Financial, Inc. (NYSE:WDR) to report earnings on January, 30. They expect $0.40 EPS, down 16.67% or $0.08 from last year’s $0.48 per share. WDR’s profit will be $33.42M for 12.04 P/E if the $0.40 EPS becomes a reality. After $0.45 actual EPS reported by Waddell & Reed Financial, Inc. for the previous quarter, Wall Street now forecasts -11.11% negative EPS growth. Investors sentiment decreased to 0.9 in 2017 Q2. Its down 0.06, from 0.96 in 2017Q1. It dropped, as 72 investors sold MDT shares while 449 reduced holdings. 99 funds opened positions while 370 raised stakes. 1.06 billion shares or 2.23% less from 1.08 billion shares in 2017Q1 were reported. Wealthfront has invested 0.04% in Medtronic plc. Ordinary Shares (NYSE:MDT). Oxbow Advsr Limited stated it has 27,042 shares or 0.42% of all its holdings. Aimz Advsr Lc holds 1.46% or 19,508 shares in its portfolio. Folger Nolan Fleming Douglas Cap Incorporated owns 4,831 shares for 0.07% of their portfolio. First Manhattan, New York-based fund reported 300,769 shares. Triangle Secs Wealth accumulated 0.26% or 4,396 shares. Howe Rusling holds 84,035 shares or 1.52% of its portfolio. Cim Limited Liability Corporation stated it has 0.11% in Medtronic plc. Ordinary Shares (NYSE:MDT). Thompson Rubinstein Investment Inc Or owns 50,678 shares. Convergence Investment Prtn Ltd Liability Co reported 2,319 shares stake. Shufro Rose Communication owns 10,331 shares or 0.1% of their US portfolio. Hartline Investment reported 22,654 shares. Glenview National Bank Dept holds 0.26% or 5,696 shares in its portfolio. Ogorek Anthony Joseph New York Adv reported 8,200 shares. Security Commercial Bank Of Sioux City Iowa Ia invested 2.54% of its portfolio in Medtronic plc. Ordinary Shares (NYSE:MDT).Tiedemann Wealth Management Llc decreased Mondelez Intl Inc (NASDAQ:MDLZ) stake by 7,500 shares to 25,442 valued at $1.10M in 2017Q2. It also reduced Molina Healthcare Inc (NYSE:MOH) stake by 72,123 shares and now owns 1.34M shares. Ishares S&P Mid (IJH) was reduced too. Among 27 analysts covering Medtronic (NYSE:MDT), 17 have Buy rating, 0 Sell and 10 Hold. Therefore 63% are positive. Medtronic had 74 analyst reports since August 10, 2015 according to SRatingsIntel. The firm has “Buy” rating given on Tuesday, August 23 by Citigroup. The firm earned “Neutral” rating on Thursday, June 9 by Guggenheim. The rating was maintained by Jefferies with “Hold” on Friday, September 4. The company was maintained on Friday, November 10 by BMO Capital Markets. As per Tuesday, November 21, the company rating was maintained by Needham. The firm has “Buy” rating given on Monday, July 31 by Deutsche Bank. The rating was maintained by William Blair with “Outperform” on Thursday, July 6. The rating was maintained by RBC Capital Markets on Tuesday, September 29 with “Outperform”. Evercore upgraded the stock to “Buy” rating in Thursday, October 8 report. As per Wednesday, November 22, the company rating was maintained by Stifel Nicolaus.Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.


		var data = "63557954";
		document.write('<ins class="adsbygoogle" style="background-color:transparent; display:inline-block;width:300px;height:600px;" data-ad-client="ca-pub-16900'+data+'675" data-ad-slot="7169126944"></ins>')
	
(adsbygoogle = window.adsbygoogle || []).push({});